Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04586400 · ClinicalTrials.gov registry record
Chromosome 9 P Minus Syndrome
A clinical trial of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04586400: Recruiting study of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome, sponsored by Washington University School of Medicine.
NCT04586400 is a study of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04586400, a study of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with deletion of chromosome 9 P are rare (\~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic background in affected patients (whole genome sequencing) and correlate the genes in the deleted portion of chromosome 9 P with specific phenotypic characteristics of each patient. Enrolled participants will be asked to complete a detailed questionnaire, complete a medical release form, and provide a biospecimen sample.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2026-06 |
What NCT04586400 shows while recruiting
NCT04586400 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 5 conditions, with Chromosome 9P Deletion Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT04586400 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04586400 about?
NCT04586400 is a clinical study titled "Chromosome 9 P Minus Syndrome". Patients with deletion of chromosome 9 P are rare (\~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic backgr...
What is the current status of trial NCT04586400?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-06-27. Estimated completion is 2026-06.
What conditions does trial NCT04586400 study?
This clinical trial studies the following conditions: Chromosome 9P Deletion Syndrome, 9p Minus Syndrome, Alfi Syndrome, 9P Monosomy, 9P Partial Monosomy Syndrome.
Who is sponsoring clinical trial NCT04586400?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04586400 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI